Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn

Details Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn

1989-04-10

1990-08-14

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540455, A61K 31395, C07D52100

Patent

active

049487914

ABSTRACT:
Novel didemnin compounds named didemnin X and didemnin Y have been isolated from the Caribbean tunicate Trididemnum solidum. These compounds have cytotoxic activity and, therefore, are useful as antitumor drugs.

REFERENCES:
patent: 4668669 (1987-05-01), Barriere et al.

Affiliated with

Also associated with

Rating

Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel Cytotoxic cyclic depsipeptides from the tunicate trididemn will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-463144